Home LiteratureArticle Details
PMID: 17114290 Published · ppublish English Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Increased prevalence of insulin resistance and nonalcoholic fatty liver disease in Asian-Indian men.

Petersen KF, Dufour S, Feng J, Befroy D, Dziura J, Dalla Man C, Cobelli C, Shulman GI

Abstract

Type 2 diabetes mellitus (T2DM) is strongly associated with obesity in most, but not all, ethnic groups, suggesting important ethnic differences in disease susceptibility. Although it is clear that insulin resistance plays a major role in the pathogenesis of T2DM and that insulin resistance is strongly associated with increases in hepatic (HTG) and/or intramyocellular lipid content, little is known about the prevalence of insulin resistance and potential differences in intracellular lipid distribution among healthy, young, lean individuals of different ethnic groups. To examine this question, 482 young, lean, healthy, sedentary, nonsmoking Eastern Asians (n = 49), Asian-Indians (n = 59), Blacks (n = 48), Caucasians (n = 292), and Hispanics (n = 34) underwent an oral glucose tolerance test to assess whole-body insulin sensitivity by an insulin sensitivity index. In addition, intramyocellular lipid and HTG contents were measured by using proton magnetic resonance spectroscopy. The prevalence of insulin resistance, defined as the lower quartile of insulin sensitivity index, was approximately 2- to 3-fold higher in the Asian-Indians compared with all other ethnic groups, and this could entirely be attributed to a 3- to 4-fold increased prevalence of insulin resistance in Asian-Indian men. This increased prevalence of insulin resistance in the Asian-Indian men was associated with an approximately 2-fold increase in HTG content and plasma IL-6 concentrations compared with Caucasian men. These data demonstrate important ethnic and gender differences in the pathogenesis of insulin resistance in Asian-Indian men and have important therapeutic implications for treatment of T2DM and for the development of steatosis-related liver disease in this ethnic group.

MeSH Terms
Adipose Tissue Adult Cytokines/blood Fatty Liver/epidemiology,metabolism Female Humans India/epidemiology Insulin Resistance Insulin-Secreting Cells/metabolism Male Prevalence Sex Characteristics Triglycerides/metabolism
Chemicals
Cytokines Triglycerides
Authors & Affiliations
8 authors, click to expand affiliations / ORCID
Petersen Kitt Falk
Department of Internal Medicine, Yale University School of Medicine, New Haven, CT 06536, USA.
Dufour Sylvie
Feng Jing
Befroy Douglas
Dziura James
Dalla Man Chiara
Cobelli Claudio
Shulman Gerald I
References (41)
41 references, click to expand
  1. Insulin resistance as the core defect in type 2 diabetes mellitus.
    Am J Cardiol. 2002 Sep 5;90(5A):3G-10G PMID: 12231073
  2. Leptin reverses insulin resistance and hepatic steatosis in patients with severe lipodystrophy.
    J Clin Invest. 2002 May;109(10):1345-50 PMID: 12021250
  3. Pioglitazone reduces hepatic fat content and augments splanchnic glucose uptake in patients with type 2 diabetes.
    Diabetes. 2003 Jun;52(6):1364-70 PMID: 12765945
  4. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies.
    Lancet. 2004 Jan 10;363(9403):157-63 PMID: 14726171
  5. Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes.
    N Engl J Med. 2004 Feb 12;350(7):664-71 PMID: 14960743
  6. Differential effects of interleukin-6 and -10 on skeletal muscle and liver insulin action in vivo.
    Diabetes. 2004 Apr;53(4):1060-7 PMID: 15047622
  7. Mechanism of hepatic insulin resistance in non-alcoholic fatty liver disease.
    J Biol Chem. 2004 Jul 30;279(31):32345-53 PMID: 15166226
  8. Insulin resistance and vascular dysfunction in nondiabetic Asian Indians.
    J Clin Endocrinol Metab. 2004 Aug;89(8):3965-72 PMID: 15292334
  9. A short questionnaire for the measurement of habitual physical activity in epidemiological studies.
    Am J Clin Nutr. 1982 Nov;36(5):936-42 PMID: 7137077
  10. A microfluorometric method for the determination of free fatty acids in plasma.
    J Lipid Res. 1983 Jan;24(1):96-9 PMID: 6833886
  11. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man.
    Diabetologia. 1985 Jul;28(7):412-9 PMID: 3899825
  12. Relation of central obesity and insulin resistance with high diabetes prevalence and cardiovascular risk in South Asians.
    Lancet. 1991 Feb 16;337(8738):382-6 PMID: 1671422
  13. What if Minkowski had been ageusic? An alternative angle on diabetes.
    Science. 1992 Oct 30;258(5083):766-70 PMID: 1439783
  14. Abdominal obesity and the metabolic syndrome.
    Ann Med. 1992 Dec;24(6):465-8 PMID: 1485940
  15. Global estimates for prevalence of diabetes mellitus and impaired glucose tolerance in adults. WHO Ad Hoc Diabetes Reporting Group.
    Diabetes Care. 1993 Jan;16(1):157-77 PMID: 8123057
  16. Intramyocellular lipid concentrations are correlated with insulin sensitivity in humans: a 1H NMR spectroscopy study.
    Diabetologia. 1999 Jan;42(1):113-6 PMID: 10027589
  17. Intramyocellular triglyceride content is a determinant of in vivo insulin resistance in humans: a 1H-13C nuclear magnetic resonance spectroscopy assessment in offspring of type 2 diabetic parents.
    Diabetes. 1999 Aug;48(8):1600-6 PMID: 10426379
  18. Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp.
    Diabetes Care. 1999 Sep;22(9):1462-70 PMID: 10480510
  19. Association of simple anthropometric measures of obesity with visceral fat and the metabolic syndrome in male Caucasian and Indo-Asian subjects.
    Diabet Med. 2004 Dec;21(12):1339-45 PMID: 15569138
  20. Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity.
    Hepatology. 2004 Dec;40(6):1387-95 PMID: 15565570
  21. Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population.
    Am J Physiol Endocrinol Metab. 2005 Feb;288(2):E462-8 PMID: 15339742
  22. Molecular evidence supporting the portal theory: a causative link between visceral adiposity and hepatic insulin resistance.
    Am J Physiol Endocrinol Metab. 2005 Feb;288(2):E454-61 PMID: 15522994
  23. Reversal of nonalcoholic hepatic steatosis, hepatic insulin resistance, and hyperglycemia by moderate weight reduction in patients with type 2 diabetes.
    Diabetes. 2005 Mar;54(3):603-8 PMID: 15734833
  24. Inflammation, stress, and diabetes.
    J Clin Invest. 2005 May;115(5):1111-9 PMID: 15864338
  25. Prevention of hepatic steatosis and hepatic insulin resistance in mitochondrial acyl-CoA:glycerol-sn-3-phosphate acyltransferase 1 knockout mice.
    Cell Metab. 2005 Jul;2(1):55-65 PMID: 16054099
  26. Differential regulation of insulin resistance and hypertension by sex hormones in fructose-fed male rats.
    Am J Physiol Heart Circ Physiol. 2005 Oct;289(4):H1335-42 PMID: 15951347
  27. Two-hour seven-sample oral glucose tolerance test and meal protocol: minimal model assessment of beta-cell responsivity and insulin sensitivity in nondiabetic individuals.
    Diabetes. 2005 Nov;54(11):3265-73 PMID: 16249454
  28. The Indian Diabetes Prevention Programme shows that lifestyle modification and metformin prevent type 2 diabetes in Asian Indian subjects with impaired glucose tolerance (IDPP-1).
    Diabetologia. 2006 Feb;49(2):289-97 PMID: 16391903
  29. Reversal of diet-induced hepatic steatosis and hepatic insulin resistance by antisense oligonucleotide inhibitors of acetyl-CoA carboxylases 1 and 2.
    J Clin Invest. 2006 Mar;116(3):817-24 PMID: 16485039
  30. Fat accumulation in the liver is associated with defects in insulin suppression of glucose production and serum free fatty acids independent of obesity in normal men.
    J Clin Endocrinol Metab. 2002 Jul;87(7):3023-8 PMID: 12107194
  31. Mechanism of insulin resistance in A-ZIP/F-1 fatless mice.
    J Biol Chem. 2000 Mar 24;275(12):8456-60 PMID: 10722680
  32. Cellular mechanisms of insulin resistance.
    J Clin Invest. 2000 Jul;106(2):171-6 PMID: 10903330
  33. Insulin sensitivity differs among ethnic groups with a compensatory response in beta-cell function.
    Diabetes Care. 2000 Sep;23(9):1353-8 PMID: 10977032
  34. Oral glucose tolerance test minimal model indexes of beta-cell function and insulin sensitivity.
    Diabetes. 2001 Jan;50(1):150-8 PMID: 11147781
  35. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance.
    N Engl J Med. 2001 May 3;344(18):1343-50 PMID: 11333990
  36. Tissue-specific overexpression of lipoprotein lipase causes tissue-specific insulin resistance.
    Proc Natl Acad Sci U S A. 2001 Jun 19;98(13):7522-7 PMID: 11390966
  37. Global and societal implications of the diabetes epidemic.
    Nature. 2001 Dec 13;414(6865):782-7 PMID: 11742409
  38. Insulin release in impaired glucose tolerance: oral minimal model predicts normal sensitivity to glucose but defective response times.
    Diabetes. 2002 Feb;51 Suppl 1:S227-33 PMID: 11815484
  39. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin.
    N Engl J Med. 2002 Feb 7;346(6):393-403 PMID: 11832527
  40. The effects of rosiglitazone on insulin sensitivity, lipolysis, and hepatic and skeletal muscle triglyceride content in patients with type 2 diabetes.
    Diabetes. 2002 Mar;51(3):797-802 PMID: 11872682
  41. Female rats are protected against fructose-induced changes in metabolism and blood pressure.
    Am J Physiol Heart Circ Physiol. 2002 Dec;283(6):H2478-84 PMID: 12427595
Article Info
Journal
Proceedings of the National Academy of Sciences of the United States of America
Abbr.
Proc Natl Acad Sci U S A
ISSN
0027-8424
Published
2006-11-28
Epub
2006-00-17
Pages
18273-7
Language
English
Region
United States
NLM ID
7505876
PMCID
PMC1693873
Subset
IM
Grants
NIDDK NIH HHS · R01 DK049230 · United States
NIA NIH HHS · R01 AG023686-05 · United States
NIDDK NIH HHS · P01 DK-068229 · United States
NIDDK NIH HHS · P01 DK068229 · United States
NIDDK NIH HHS · P30 DK-45735 · United States
NIA NIH HHS · R01 AG023686 · United States
NIDDK NIH HHS · P30 DK045735 · United States
NIDDK NIH HHS · R01 DK-49230 · United States
NCRR NIH HHS · M01 RR-00125 · United States
NIA NIH HHS · R01 AG-23686 · United States
NCRR NIH HHS · M01 RR000125 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]